This is what I am referring to:
Phase III Clinical PathwayProposed Phase III Clinical pathwayIntroductionTissue Repair has commenced preparatory work for the TR-987 Phase III clinical trial on venous leg ulcers and is expecting the study to take an estimated 36 months to complete, assuming no delays in patient recruitment, or onerous FDA requests in relation to the characterisation of the active ingredient, Glucoprime.Proposed Phase III
Tissue Repair: Hidden Gem in Biotech!, page-99
-
- There are more pages in this discussion • 77 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TRP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.010(2.82%) |
Mkt cap ! $20.86M | |||
| Open | High | Low | Value | Volume |
| 35.0¢ | 35.0¢ | 34.0¢ | $9.58K | 27.83K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 11600 | 33.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 6296 | 2 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| TRP (ASX) Chart |